Abionyx Pharma SA (ABNX) — Financial Flexibility Index

Latest as of June 2025: -0.20x

Abionyx Pharma SA (ABNX) has a Financial Flexibility Index of -0.20x as of June 2025. Free cash flow of €-1.54 Million (operating CF €-1.70 Million minus capex €162.00K) represents 0% of total liabilities (€7.56 Million). Check ABNX strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

-0.20x
Free Cash Flow / Total Liabilities

Free Cash Flow

€-1.54 Million
Operating CF − Capex

Total Liabilities

€7.56 Million
EUR

Capital Expenditures

€162.00K
EUR

Abionyx Pharma SA Financial Flexibility Index (2013–2024)

Historical Financial Flexibility Index trend for Abionyx Pharma SA across 12 annual periods. See Abionyx Pharma SA (ABNX) working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Abionyx Pharma SA (2013–2024)

Year-by-year free cash flow to debt coverage for Abionyx Pharma SA. For the full company profile including market capitalisation, see Abionyx Pharma SA (ABNX) total market value.

Year Flexibility Index Free Cash Flow (EUR) Operating CF Total Liabilities YoY Change
2024 -0.58x €-3.52 Million €-3.60 Million €6.03 Million ▼ -13.3%
2023 -0.52x €-3.57 Million €-3.70 Million €6.91 Million ▼ -40.3%
2022 -0.37x €-3.18 Million €-3.36 Million €8.65 Million ▲ +37.1%
2021 -0.59x €-6.53 Million €-6.69 Million €11.15 Million ▼ -374.6%
2020 -0.12x €-451.00K €-599.00K €3.66 Million ▲ +88.5%
2019 -1.07x €-3.85 Million €-3.95 Million €3.58 Million ▼ -67.0%
2018 -0.64x €-5.98 Million €-6.00 Million €9.30 Million ▲ +31.9%
2017 -0.94x €-8.88 Million €-9.09 Million €9.41 Million ▲ +28.9%
2016 -1.33x €-19.19 Million €-19.20 Million €14.46 Million ▼ -26.6%
2015 -1.05x €-13.54 Million €-13.71 Million €12.91 Million ▼ -244.1%
2014 -0.30x €-3.30 Million €-3.30 Million €10.82 Million ▲ +83.7%
2013 -1.87x €-14.48 Million €-14.49 Million €7.76 Million —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities